AZD7762

DRUG3 trials

Sponsors

AstraZeneca

Conditions

Advanced Solid MalignanciesAdvanced Solid TumorsCancerSolid Tumors

Phase 1

Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies

CompletedNCT00413686

AstraZenecaSolid Tumors

Start: 2006-12-31End: 2010-05-31Updated: 2010-12-06

Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan

TerminatedNCT00473616

AstraZenecaAdvanced Solid Malignancies, Advanced Solid Tumors, Cancer

Start: 2007-05-31End: 2011-01-31Target: 60Updated: 2011-02-11

Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine

TerminatedNCT00937664

AstraZenecaAdvanced Solid Malignancies, Cancer, Solid Tumors

Start: 2009-07-31End: 2011-02-28Updated: 2011-02-07

Related Papers

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours.

2013-07-2878 citations